KZIA - What's Going On With Kazia Therapeutics Shares Thursday? | Benzinga
Kazia Therapeutics (NASDAQ:KZIA) stock is trading higher on Thursday on possible continued momentum from the company’s Wednesday press release.
The Details: The company announced results from its Phase II/III trial in regards to the treatment of glioblastoma, a type of brain cancer.
The trial, containing 313 participants, compared the effectiveness of paxalisib versus the current standard of care. The results showed a 3.8 month increase in overall survival, or about a ...